Extranodal NK-T-cell lymphoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
* The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as [[Wegener's granulomatosis|Wegener's Granulomatosis]] was ruled out. | * The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as [[Wegener's granulomatosis|Wegener's Granulomatosis]] was ruled out. | ||
*In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the [[Leukemia|leukemic disease]].<ref name="SawadaInoue2018">{{cite journal|last1=Sawada|first1=Akihisa|last2=Inoue|first2=Masami|title=Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders|journal=Frontiers in Pediatrics|volume=6|year=2018|issn=2296-2360|doi=10.3389/fped.2018.00334}}</ref> | *In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the [[Leukemia|leukemic disease]].<ref name="SawadaInoue2018">{{cite journal|last1=Sawada|first1=Akihisa|last2=Inoue|first2=Masami|title=Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders|journal=Frontiers in Pediatrics|volume=6|year=2018|issn=2296-2360|doi=10.3389/fped.2018.00334}}</ref> | ||
* Reanalysis of stored slides of 1965 revealed an [[Immunophenotyping|immunophenotype]] typical of [[NK cell]] which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood. | * Reanalysis of stored slides of 1965 revealed an [[Immunophenotyping|immunophenotype]] typical of [[NK cell]] which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood. | ||
* Biopsy specimen collected in 1998 and 2002 contained [[EBV]] [[virus]] encoded [[RNA]] transcripts and then diagnosed as a natural-killer-cell lymphoma. | * Biopsy specimen collected in 1998 and 2002 contained [[EBV]] [[virus]] encoded [[RNA]] transcripts and then diagnosed as a natural-killer-cell lymphoma. | ||
Revision as of 17:17, 28 October 2019
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma historical perspective |
|
Extranodal NK-T-cell lymphoma historical perspective in the news |
|
Blogs on Extranodal NK-T-cell lymphoma historical perspective |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma. The natural history of extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "rhinitis gangrenosa progressiva". Since the lesions usually was in midline and was aggressive and lethal, the term "lethal midline granuloma (LMG)" was used. First known case of natural-killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
Historical Perspective
Discovery
- Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma.[1]
- The natural history of extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "rhinitis gangrenosa progressiva".[2]
- Since the lesions usually was in midline and was aggressive and lethal, the term "lethal midline granuloma (LMG)" was used.[3]
- First known case of natural-killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.[4]
- Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified sarcoma.
- The diagnosis of natural-killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
- In 1988, 33 years after the first confirmed diagnosis of NK cell lymphoma, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the leukemic disease.[5]
- Reanalysis of stored slides of 1965 revealed an immunophenotype typical of NK cell which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.
- Biopsy specimen collected in 1998 and 2002 contained EBV virus encoded RNA transcripts and then diagnosed as a natural-killer-cell lymphoma.
References
- ↑ Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T (2019). "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress". Front Pediatr. 7: 141. doi:10.3389/fped.2019.00141. PMC 6476925. PMID 31041299.
- ↑ McBride P (1991). "Photographs of a case of rapid destruction of the nose and face. 1897". J Laryngol Otol. 105 (12): 1120. doi:10.1017/s0022215100118407. PMID 1787378.
- ↑ Aozasa, Katsuyuki; Takakuwa, Tetsuya; Hongyo, Tadashi; Yang, Woo-Ick (2008). "Nasal NK/T-cell lymphoma: epidemiology and pathogenesis". International Journal of Hematology. 87 (2): 110–117. doi:10.1007/s12185-008-0021-7. ISSN 0925-5710.
- ↑ Schrader C, Janssen D, Kneba M, Lennert K (2004). "A 38-year history of natural-killer-cell lymphoma". N Engl J Med. 350 (4): 418–9. doi:10.1056/NEJM200401223500423. PMID 14736941.
- ↑ Sawada, Akihisa; Inoue, Masami (2018). "Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00334. ISSN 2296-2360.